Authors: Lhomme, C Vermorken, JB Mickiewicz, E Chevalier, B Alvarez, A Mendiola, C Pawinski, A Lentz, MA Pecorelli, S

Citation: C. Lhomme et al., Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study, EUR J CANC, 36(2), 2000, pp. 194-199

Authors: Roche, H Cure, H Adenis, A Fargeot, P Terret, C Lentz, MA Madelmont, JC Fumoleau, P Hanauske, A Chollet, P

Citation: H. Roche et al., Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults, J NEURO-ONC, 49(2), 2000, pp. 141-145

Authors: Cure, H Souteyrand, P Ouabdesselam, R Roche, H Ravaud, A D'incan, M Viens, P Fargeot, P Lentz, MA Fumoleau, P Hanauske, A Chollet, P

Citation: H. Cure et al., Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- orsecond-line treatment in advanced malignant melanoma: a trial of the EORTCClinical Studies Group, MELANOMA RE, 9(6), 1999, pp. 607-610

Authors: Pawinski, A Crowther, D Keizer, HJ Voute, PA Somers, R van Glabbeke, M Lentz, MA van Oosterom, AT

Citation: A. Pawinski et al., The EORTC phase II study of iproplatin in advanced osteogenic sarcoma, EUR J CANC, 35(1), 1999, pp. 163-164

Authors: Lhomme, C Fumoleau, P Fargeot, P Krakowski, Y Dieras, V Chauvergne, J Vennin, P Rebattu, P Roche, H Misset, JL Lentz, MA Van Glabbeke, M Matthieu-Boue, A Mignard, D Chevallier, B

Citation: C. Lhomme et al., Results of a European organization for research and treatment of cancer/early clinical studies group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix, J CL ONCOL, 17(10), 1999, pp. 3136-3142